The study reconfirmed the association of the unveiled core genes, VPS53, SCGN, RGS6, SGCG, and FOXN3, with NAFLD and T2D, which had been reported in previous studies. This evidence concerns the gene VPS53 and metabolic dysfunction-associated steatotic liver disease.